| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
248,087 |
220,802 |
$9.81M |
| 88142 |
|
334,150 |
308,163 |
$7.12M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
53,576 |
47,435 |
$5.18M |
| 87590 |
|
161,713 |
144,902 |
$3.70M |
| 87490 |
|
161,716 |
144,905 |
$3.67M |
| 88365 |
|
37,160 |
34,173 |
$3.47M |
| 88182 |
|
36,296 |
33,481 |
$2.83M |
| 88187 |
|
37,239 |
34,232 |
$1.70M |
| 88184 |
|
37,596 |
34,461 |
$1.25M |
| 88342 |
|
11,692 |
9,998 |
$1.16M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
33,517 |
25,051 |
$1.01M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
33,520 |
25,056 |
$1.01M |
| 88341 |
|
5,464 |
4,334 |
$987K |
| 88185 |
|
37,309 |
34,299 |
$617K |
| 88141 |
|
25,144 |
20,767 |
$489K |
| 88344 |
|
1,407 |
1,279 |
$456K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13,637 |
7,556 |
$307K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
8,110 |
4,875 |
$243K |
| 88307 |
|
882 |
774 |
$148K |
| 88150 |
|
10,799 |
10,038 |
$138K |
| 88104 |
|
3,090 |
2,292 |
$124K |
| 88304 |
|
3,038 |
2,746 |
$100K |
| 88302 |
|
804 |
720 |
$39K |
| 88300 |
|
2,235 |
2,003 |
$22K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
735 |
731 |
$22K |
| 88312 |
|
128 |
117 |
$17K |
| 88164 |
|
959 |
922 |
$10K |
| 87625 |
|
213 |
213 |
$6K |
| 87070 |
|
437 |
384 |
$4K |